Upgrade to SI Premium - Free Trial

Pacira Pharma (PCRX) Tops Q3 EPS by 15c

November 7, 2019 8:12 AM
Pacira Pharma (NASDAQ: PCRX) reported Q3 EPS of $0.48, $0.15 better than the analyst estimate of $0.33. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles